Cristina Flores

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 277 citations

Immunology, Clinical Trials, Gastroenterology +7

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Heda M B S Amarante et al. · World Journal of Gastroenterology · 2019 · 82 citations · Full text

Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital

Cristina Flores, Ismael Maguilnik, Everton Hadlich et al. · Journal of Gastroenterology and Hepatology · 2003 · 66 citations

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 62 citations · Full text

Placebo-controlled Induction, Gastroenterology, Pathology +6

Comparison Between Handgrip Strength, Subjective Global Assessment, Anthropometry, and Biochemical Markers in Assessing Nutritional Status of Patients with Crohn’s Disease in Clinical Remission

Céres Maltz Bin, Cristina Flores, Mário Reis Álvares‐da‐Silva et al. · Digestive Diseases and Sciences · 2009 · 55 citations

Nutrition, Biochemical Markers, Clinical Nutrition +9